{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T06:21:22Z","timestamp":1785392482061,"version":"3.55.0"},"reference-count":31,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.3892\/ol.2015.3951","type":"journal-article","created":{"date-parts":[[2015,11,20]],"date-time":"2015-11-20T11:21:01Z","timestamp":1448018461000},"page":"870-878","source":"Crossref","is-referenced-by-count":20,"title":["Truncated neurokinin-1 receptor is an ubiquitous antitumor target in hepatoblastoma, and its expression is independent of tumor biology and stage"],"prefix":"10.3892","volume":"11","author":[{"given":"AGN\u00c8S","family":"GARNIER","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MATTHIAS","family":"ILMER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KRISTINA","family":"BECKER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BEATE","family":"H\u00c4BERLE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DIETRICH","family":"VON SCHWEINITZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ROLAND","family":"KAPPLER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MICHAEL","family":"BERGER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,11,20]]},"reference":[{"key":"key20180108095453_b1-ol-0-0-3951","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/j.sempedsurg.2011.10.011","article-title":"Hepatoblastoma: Recent developments in research and treatment","volume":"21","author":"von Schweinitz","year":"2012","journal-title":"Semin Pediatr Surg"},{"key":"key20180108095453_b2-ol-0-0-3951","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2741\/e395","article-title":"Treatment of hepatoblastoma in the German cooperative pediatric liver tumor studies","volume":"4","author":"Haeberle","year":"2012","journal-title":"Front Biosci (Elite Ed)"},{"key":"key20180108095453_b3-ol-0-0-3951","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1002\/cncr.10858","article-title":"The role of the MDR1 gene in the development of multidrug resistance in human hepatoblastoma: Clinical course and in vivo model","volume":"95","author":"Warmann","year":"2002","journal-title":"Cancer"},{"key":"key20180108095453_b4-ol-0-0-3951","doi-asserted-by":"crossref","first-page":"909","DOI":"10.2174\/138945011795528796","article-title":"The NK-1 receptor: A new target in cancer therapy","volume":"12","author":"Mu\u00f1oz","year":"2011","journal-title":"Curr Drug Targets"},{"key":"key20180108095453_b5-ol-0-0-3951","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1054\/bjoc.1999.0946","article-title":"Anti-tumour activity of tachykinin NK1 receptor antagonists on human glioma U373 MG xenograft","volume":"82","author":"Palma","year":"2000","journal-title":"Br J Cancer"},{"key":"key20180108095453_b6-ol-0-0-3951","first-page":"381434","article-title":"The role of neurokinin-1 receptor in the microenvironment of inflammation and cancer","volume":"2012","author":"Rosso","year":"2012","journal-title":"ScientificWorldJournal"},{"key":"key20180108095453_b7-ol-0-0-3951","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2174\/092986710790416308","article-title":"A new frontier in the treatment of cancer: NK-1 receptor antagonists","volume":"17","author":"Mu\u00f1oz","year":"2010","journal-title":"Curr Med Chem"},{"key":"key20180108095453_b8-ol-0-0-3951","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jhep.2013.12.024","article-title":"Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.","volume":"60","author":"Berger","year":"2014","journal-title":"J Hepatol"},{"key":"key20180108095453_b9-ol-0-0-3951","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/01.cmr.0000129376.22141.a3","article-title":"Antitumoral action of the neurokinin-1 receptor antagonist L-733 060 on human melanoma cell lines","volume":"14","author":"Mu\u00f1oz","year":"2004","journal-title":"Melanoma Res"},{"key":"key20180108095453_b10-ol-0-0-3951","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/jcp.22848","article-title":"Targeting of substance P induces cancer cell death and decreases the steady state of EGFR and Her2","volume":"227","author":"Mayordomo","year":"2012","journal-title":"J Cell Physiol"},{"key":"key20180108095453_b11-ol-0-0-3951","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3892\/ijo.2013.2164","article-title":"Antitumor activity of neurokinin-1 receptor antagonists in MG-63 human osteosarcoma xenografts","volume":"44","author":"Mu\u00f1oz","year":"2014","journal-title":"Int J Oncol"},{"key":"key20180108095453_b12-ol-0-0-3951","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1126\/science.281.5383.1640","article-title":"Distinct mechanism for antidepressant activity by blockade of central substance P receptors","volume":"281","author":"Kramer","year":"1998","journal-title":"Science"},{"key":"key20180108095453_b13-ol-0-0-3951","doi-asserted-by":"crossref","first-page":"17420","DOI":"10.1073\/pnas.1114275108","article-title":"Truncated neurokinin-1 receptor is increased in colonic epithelial cells from patients with colitis-associated cancer","volume":"108","author":"Gillespie","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108095453_b14-ol-0-0-3951","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1158\/0008-5472.CAN-06-3813","article-title":"Nuclear factor-kappaB is central to the expression of truncated neurokinin-1 receptor in breast cancer: Implication for breast cancer cell quiescence within bone marrow stroma","volume":"67","author":"Ramkissoon","year":"2007","journal-title":"Cancer Res"},{"key":"key20180108095453_b15-ol-0-0-3951","doi-asserted-by":"crossref","first-page":"17436","DOI":"10.1073\/pnas.0506351102","article-title":"Transformation of breast cells by truncated neurokinin-1 receptor is secondary to activation by preprotachykinin-A peptides","volume":"102","author":"Patel","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108095453_b16-ol-0-0-3951","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ccr.2008.11.002","article-title":"Hepatic stem-like phenotype and interplay of Wnt\/\u03b2-catenin and Myc signaling in aggressive childhood liver cancer","volume":"14","author":"Cairo","year":"2008","journal-title":"Cancer Cell"},{"key":"key20180108095453_b17-ol-0-0-3951","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2741\/e393","article-title":"Activation of Wnt and Myc signaling in hepatoblastoma","volume":"4","author":"Cairo","year":"2012","journal-title":"Front Biosci (Elite Ed)"},{"key":"key20180108095453_b18-ol-0-0-3951","doi-asserted-by":"crossref","first-page":"6424","DOI":"10.1158\/0008-5472.CAN-12-4573","article-title":"Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer","volume":"73","author":"Garcia-Recio","year":"2013","journal-title":"Cancer Res"},{"key":"key20180108095453_b19-ol-0-0-3951","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10555-006-8161-9","article-title":"A role for substance P in cancer promotion and progression: A mechanism to counteract intracellular death signals following oncogene activation or DNA damage","volume":"25","author":"Esteban","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"key20180108095453_b20-ol-0-0-3951","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1365-2559.2008.03193.x","article-title":"Expression of substance P and neurokinin-1-receptor in laryngeal cancer: Linking chronic inflammation to cancer promotion and progression","volume":"54","author":"Esteban","year":"2009","journal-title":"Histopathology"},{"key":"key20180108095453_b21-ol-0-0-3951","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s10585-006-9001-6","article-title":"The expression of neurokinin-1 and preprotachykinin-1 in breast cancer cells depends on the relative degree of invasive and metastatic potential","volume":"22","author":"Castro","year":"2005","journal-title":"Clin Exp Metastasis"},{"key":"key20180108095453_b22-ol-0-0-3951","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00432-013-1393-5","article-title":"Frequent promoter hypermethylation of tachykinin-1 and tachykinin receptor type 1 is a potential biomarker for head and neck cancer","volume":"139","author":"Misawa","year":"2013","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20180108095453_b23-ol-0-0-3951","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1200\/JCO.2000.18.22.3819","article-title":"Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: A successful approach - results of the first prospective study of the International Society of Pediatric Oncology","volume":"18","author":"Pritchard","year":"2000","journal-title":"J Clin Oncol"},{"key":"key20180108095453_b24-ol-0-0-3951","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00247-006-0361-5","article-title":"International Childrhood Liver Tumor Strategy Group: PRETEXT: A revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group","volume":"37","author":"Roebuck","year":"2007","journal-title":"Pediatr Radiol"},{"key":"key20180108095453_b25-ol-0-0-3951","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jhep.2014.08.009","article-title":"The genomic landscape of hepatoblastoma and their progenies with HCC-like features","volume":"61","author":"Eichenm\u00fcller","year":"2014","journal-title":"J Hepatol"},{"key":"key20180108095453_b26-ol-0-0-3951","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/hep.22649","article-title":"Blocking the hedgehog pathway inhibits hepatoblastoma growth","volume":"49","author":"Eichenm\u00fcller","year":"2009","journal-title":"Hepatology"},{"key":"key20180108095453_b27-ol-0-0-3951","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/00001813-200511000-00007","article-title":"Role of NK-1 and NK-2 tachykinin receptor antagonism on the growth of human breast carcinoma cell line MDA-MB-231","volume":"16","author":"Bigioni","year":"2005","journal-title":"Anticancer Drugs"},{"key":"key20180108095453_b28-ol-0-0-3951","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"key20180108095453_b29-ol-0-0-3951","first-page":"305","article-title":"Neurokinin-1 receptor: A new promising target in the treatment of cancer","volume":"10","author":"Mu\u00f1oz","year":"2010","journal-title":"Discov Med"},{"key":"key20180108095453_b30-ol-0-0-3951","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10637-009-9218-8","article-title":"The NK-1 receptor antagonist aprepitant as a broad spectrum antitumor drug","volume":"28","author":"Mu\u00f1oz","year":"2010","journal-title":"Invest New Drugs"},{"key":"key20180108095453_b31-ol-0-0-3951","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1158\/1078-0432.CCR-14-2602","article-title":"Intratumor molecular and phenotypic diversity in hepatocellular carcinoma","volume":"10","author":"Nault","year":"2015","journal-title":"Clin Cancer Res"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2015.3951\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T18:50:39Z","timestamp":1567363839000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2015.3951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,20]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,11,20]]},"published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.3892\/ol.2015.3951"],"URL":"https:\/\/doi.org\/10.3892\/ol.2015.3951","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,20]]}}}